(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - hVIVO PLC on Monday said it has signed a GBP6.8 million contract with a leading Asia-Pacific pharmaceutical company, to test its respiratory synctical virus antiviral drug candidate. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - hVIVO PLC on Wednesday said it signed a GBP5.2 million contract with a "global biotechnology company" headquartered in Asia Pacific in order to test their respiratory syncytial virus vaccine candidate. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - hVivo PLC is targeting a profit by 2020, it said on Thursday, with a strong pipeline of work opportunities lying ahead.hVivo, which provides clinical development services, Read More
(Alliance News) - Induction Healthcare Group PLC said Friday it has appointed Shelley Fraser as chief financial officer on an interim basis with immediate effect.She will be replacing Seb a Read More
(Alliance News) - Clinical development firm hVIVO PLC said on Tuesday that it has completed the respiratory syncytial virus human challenge study on 60-75 year-old adults for positive tests found Read More
